Previous Close | 40.50 |
Open | 40.50 |
Bid | 54.20 |
Ask | 55.50 |
Strike | 97.50 |
Expire Date | 2026-01-16 |
Day's Range | 40.50 - 40.50 |
Contract Range | N/A |
Volume | |
Open Interest | 2 |
BD's (BDX) receipt of the FDA's clearance for the use of self-collected vaginal specimens for HPV testing is likely to improve screening access to a wider female population.
Butterfly Network (BFLY) uses proprietary Ultrasound-on-Chip technology to streamline the bladder scanning process.
Investors remain optimistic about AMN Healthcare's (AMN) broad array of services.